CD20-negative relapse in B-cell lymphoma after treatment with Rituximab
- PMID: 9850038
CD20-negative relapse in B-cell lymphoma after treatment with Rituximab
Comment in
-
CD20-negative relapse after (131)I-anti-CD20 therapy.J Clin Oncol. 1999 Nov;17(11):3692-3. doi: 10.1200/JCO.1999.17.11.3692. J Clin Oncol. 1999. PMID: 10550173 No abstract available.
Comment on
-
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.J Clin Oncol. 1997 Oct;15(10):3266-74. doi: 10.1200/JCO.1997.15.10.3266. J Clin Oncol. 1997. PMID: 9336364 Clinical Trial.
-
Peripheral T-cell lymphoma after anti-CD20 antibody therapy.J Clin Oncol. 1998 Apr;16(4):1635-7. doi: 10.1200/JCO.1998.16.4.1635. J Clin Oncol. 1998. PMID: 9552080 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources